| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |